Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Prescribing menopausal hormone therapy: an evidence-based approach.

Sood R, Faubion SS, Kuhle CL, Thielen JM, Shuster LT.

Int J Womens Health. 2014 Jan 11;6:47-57. doi: 10.2147/IJWH.S38342. eCollection 2014. Review.

2.

Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.

Davey DA.

Womens Health (Lond). 2012 Mar;8(2):169-89. doi: 10.2217/whe.12.1. Review.

PMID:
22375720
3.

Menopausal hormone therapy and breast cancer.

Santen RJ.

J Steroid Biochem Mol Biol. 2014 Jul;142:52-61. doi: 10.1016/j.jsbmb.2013.06.010. Epub 2013 Jul 16.

PMID:
23871991
4.

Menopausal Hormone Therapy: Current Considerations.

Stuenkel CA.

Endocrinol Metab Clin North Am. 2015 Sep;44(3):565-85. doi: 10.1016/j.ecl.2015.05.006. Epub 2015 Jun 26. Review.

PMID:
26316244
5.

Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Masood DE, Roach EC, Beauregard KG, Khalil RA.

Curr Drug Metab. 2010 Oct;11(8):693-714. Review.

6.

Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.

Rossouw JE, Manson JE, Kaunitz AM, Anderson GL.

Obstet Gynecol. 2013 Jan;121(1):172-6. doi: http://10.1097/AOG.0b013e31827a08c8.

7.

Vascular effects of estrogenic menopausal hormone therapy.

Reslan OM, Khalil RA.

Rev Recent Clin Trials. 2012 Feb;7(1):47-70. Review.

8.

Protective effect of hormone therapy among women with hysterectomy/oophorectomy.

Chen L, Mishra GD, Dobson AJ, Wilson LF, Jones MA.

Hum Reprod. 2017 Apr 1;32(4):885-892. doi: 10.1093/humrep/dex017.

PMID:
28184451
9.
10.

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F.

J Clin Oncol. 2009 Nov 1;27(31):5138-43. doi: 10.1200/JCO.2008.21.6432. Epub 2009 Sep 14.

11.
12.

An update on menopausal hormone replacement therapy in women and cardiovascular disease.

Valdiviezo C, Lawson S, Ouyang P.

Curr Opin Endocrinol Diabetes Obes. 2013 Apr;20(2):148-55. doi: 10.1097/MED.0b013e32835ed58b. Review.

PMID:
23422240
13.

Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.

Du Y, Dören M, Melchert HU, Scheidt-Nave C, Knopf H.

BMC Womens Health. 2007 Oct 18;7:19.

14.

What the future holds for women after menopause: where we have been, where we are, and where we want to go.

Lobo RA.

Climacteric. 2014 Dec;17 Suppl 2:12-7. doi: 10.3109/13697137.2014.944497. Epub 2014 Aug 27.

PMID:
25032478
15.

Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study.

Ran SY, Yu Q, Chen Y, Lin SQ.

Climacteric. 2017 Aug;20(4):391-396. doi: 10.1080/13697137.2017.1325459. Epub 2017 May 19.

PMID:
28523945
16.

Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?

Jones ME, Schoemaker MJ, Wright L, McFadden E, Griffin J, Thomas D, Hemming J, Wright K, Ashworth A, Swerdlow AJ.

Br J Cancer. 2016 Aug 23;115(5):607-15. doi: 10.1038/bjc.2016.231. Epub 2016 Jul 28.

17.

Menopausal hormone therapy use in 17 European countries during the last decade.

Ameye L, Antoine C, Paesmans M, de Azambuja E, Rozenberg S.

Maturitas. 2014 Nov;79(3):287-91. doi: 10.1016/j.maturitas.2014.07.002. Epub 2014 Aug 4. Erratum in: Maturitas. 2015 May;81(1):237-8.

PMID:
25156453
18.

Should we abstain from treating women with endometriosis using menopausal hormone therapy, for fear of an increased ovarian cancer risk?

Rozenberg S, Antoine C, Vandromme J, Fastrez M.

Climacteric. 2015;18(4):448-52. doi: 10.3109/13697137.2015.1041905. Epub 2015 May 11.

PMID:
25958744
19.

Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.

Harman SM.

Fertil Steril. 2014 Apr;101(4):887-97. doi: 10.1016/j.fertnstert.2014.02.042. Review.

PMID:
24680648
20.

Should symptomatic menopausal women be offered hormone therapy?

Lobo RA, Bélisle S, Creasman WT, Frankel NR, Goodman NF, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S.

MedGenMed. 2006;8(3):40. Review.

Supplemental Content

Support Center